التفاصيل البيبلوغرافية
| العنوان: |
Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma. |
| المؤلفون: |
Gill, Andrew B., Rundo, Leonardo, Wan, Jonathan C. M., Lau, Doreen, Zawaideh, Jeries P., Woitek, Ramona, Zaccagna, Fulvio, Beer, Lucian, Gale, Davina, Sala, Evis, Couturier, Dominique-Laurent, Corrie, Pippa G., Rosenfeld, Nitzan, Gallagher, Ferdia A. |
| المصدر: |
Cancers; Dec2020, Vol. 12 Issue 12, p3493, 1p |
| مصطلحات موضوعية: |
CARCINOGENESIS, ALLELES, BIOMARKERS, BLOOD plasma, BODY fluid examination, COMPUTED tomography, EXTRACELLULAR space, FACTOR analysis, GENOMES, LONGITUDINAL method, MELANOMA, METASTASIS, NUCLEIC acids, OXIDOREDUCTASES, TUMOR classification, SEQUENCE analysis, BLOOD |
| مستخلص: |
Simple Summary: The analysis of circulating tumor DNA (ctDNA) concentrations in blood plasma and the radiomic analysis of tumor images (i.e., quantification of textural features on medical imaging) have both been used to provide information about cancer progression. The purpose of this study was to assess a link between these two different modalities in order to determine whether results from one can be used to predict outcomes from the other. The results show that radiomics features can predict ctDNA levels in patients with metastatic melanoma even when controlling for confounding influences such as tumor volume. This establishes the potential for new biomarkers of tumor progression that could combine the specificity of ctDNA assays with the high-resolution spatial information obtained by imaging. Clinical imaging methods, such as computed tomography (CT), are used for routine tumor response monitoring. Imaging can also reveal intratumoral, intermetastatic, and interpatient heterogeneity, which can be quantified using radiomics. Circulating tumor DNA (ctDNA) in the plasma is a sensitive and specific biomarker for response monitoring. Here we evaluated the interrelationship between circulating tumor DNA mutant allele fraction (ctDNAmaf), obtained by targeted amplicon sequencing and shallow whole genome sequencing, and radiomic measurements of CT heterogeneity in patients with stage IV melanoma. ctDNAmaf and radiomic observations were obtained from 15 patients with a total of 70 CT examinations acquired as part of a prospective trial. 26 of 39 radiomic features showed a significant relationship with log(ctDNAmaf). Principal component analysis was used to define a radiomics signature that predicted ctDNAmaf independent of lesion volume. This radiomics signature and serum lactate dehydrogenase were independent predictors of ctDNAmaf. Together, these results suggest that radiomic features and ctDNAmaf may serve as complementary clinical tools for treatment monitoring. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder